Effect of Orexin receptor antagonists for patients with Lewy bodies: Lemborexant do not make worse cognitive function and REM sleep Behavior Disorder in DLB
Lemborexant does not worsen cognitive function and WASO, and does not accentuate RBD, in patients with DLB.
Authors
- Yuta Inagawa (ORCID: https://orcid.org/0009-0000-5792-5483)
- Ryo Yamamoto (ORCID: https://orcid.org/0000-0002-0835-3324)
- Soichiro Shimizu (ORCID: https://orcid.org/0000-0003-1324-1973)
- Naoto Takenoshita
- Shoya Inagawa
Institutions
- Tokyo Medical University (JP)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_097973
- Primary Topic
- Sleep and Wakefulness Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00